ArticleThe journal of headache and pain2023

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study.

Andreas Straube et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.